Jiřina Bártková chercheuse tchèque
Bártková, Jiřina
VIAF ID: 86419259 (Personal)
Permalink: http://viaf.org/viaf/86419259
Preferred Forms
-
- 100 0 _ ‡a Jiřina Bártková ‡c chercheuse tchèque
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer | |
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers | |
ATM activation in normal human tissues and testicular cancer | |
Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth | |
Cell-cycle regulatory proteins in human wound healing | |
A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer | |
CHEK2 variant I157T may be associated with increased breast cancer risk | |
The combined status of ATM and p53 link tumor development with therapeutic response | |
Correction to Oplustilova L, et al. Cell Cycle Volume 11, Issue 20; pp. 3837–50. | |
Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients | |
Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy. | |
Deregulated overexpression of hCdt1 and hCdc6 promotes malignant behavior | |
Deregulation of the RB pathway in human testicular germ cell tumours | |
Differences in DNA double strand breaks repair in male germ cell types: lessons learned from a differential expression of Mdc1 and 53BP1. | |
Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage | |
DNA damage-induced dynamic changes in abundance and cytosol-nuclear translocation of proteins involved in translational processes, metabolism, and autophagy | |
DNA damage response and inflammatory signaling limit the MLL-ENL-induced leukemogenesis in vivo. | |
DNA damage response as an anti-cancer barrier: damage threshold and the concept of 'conditional haploinsufficiency'. | |
DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer | |
The emerging phenotype of the testicular carcinoma in situ germ cell | |
Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment | |
Evaluation ofRAD50 in familial breast cancer predisposition | |
FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome | |
Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer | |
Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research. | |
Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro | |
JMJD1C demethylates MDC1 to regulate the RNF8 and BRCA1-mediated chromatin response to DNA breaks | |
Long-distance inflammatory and genotoxic impact of cancer in vivo | |
Macrophages, nitric oxide and microRNAs are associated with DNA damage response pathway and senescence in inflammatory bowel disease | |
MiR-34a expression has an effect for lower risk of metastasis and associates with expression patterns predicting clinical outcome in breast cancer | |
Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress | |
NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer | |
NQO1 expression correlates inversely with NFκB activation in human breast cancer | |
p16INK4A is a robust in vivo biomarker of cellular aging in human skin. | |
Patterns of DNA damage response in intracranial germ cell tumors versus glioblastomas reflect cell of origin rather than brain environment: implications for the anti-tumor barrier concept and treatment | |
Replication stress, DNA damage signalling, and cytomegalovirus infection in human medulloblastomas | |
Retinoblastoma pathway defects show differential ability to activate the constitutive DNA damage response in human tumorigenesis | |
REV7 counteracts DNA double-strand break resection and affects PARP inhibition | |
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality. | |
Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16(ink4a). | |
A short acidic motif in ARF guards against mitochondrial dysfunction and melanoma susceptibility. | |
A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer | |
Thresholds of replication stress signaling in cancer development and treatment. | |
TOPBP1 regulates RAD51 phosphorylation and chromatin loading and determines PARP inhibitor sensitivity | |
TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes | |
Two new CHEK2 germ-line variants detected in breast cancer/sarcoma families negative for BRCA1, BRCA2, and TP53 gene mutations | |
Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer |